Senile psychosis

Also known as: Psychosis senile / Unspecified senile psychotic condition / Presenile dementia NOS

Drug	Drug Name	Drug Description
DB01403	Methotrimeprazine	A phenothiazine used in the management of psychosis, particular those of schizophrenia, and manic phases of bipolar disorder.

Drug	Drug Name	Target	Type
DB01403	Methotrimeprazine	Dopamine D3 receptor	target
DB01403	Methotrimeprazine	Histamine H1 receptor	target
DB01403	Methotrimeprazine	Muscarinic acetylcholine receptor M1	target
DB01403	Methotrimeprazine	Muscarinic acetylcholine receptor M2	target
DB01403	Methotrimeprazine	Muscarinic acetylcholine receptor M3	target
DB01403	Methotrimeprazine	Muscarinic acetylcholine receptor M4	target
DB01403	Methotrimeprazine	Muscarinic acetylcholine receptor M5	target
DB01403	Methotrimeprazine	Alpha-1A adrenergic receptor	target
DB01403	Methotrimeprazine	Alpha-1B adrenergic receptor	target
DB01403	Methotrimeprazine	Alpha-1D adrenergic receptor	target
DB01403	Methotrimeprazine	Cytochrome P450 2D6	enzyme
DB01403	Methotrimeprazine	Dopamine D2 receptor	target
DB01403	Methotrimeprazine	Dopamine D1 receptor	target
DB01403	Methotrimeprazine	Dopamine D5 receptor	target
DB01403	Methotrimeprazine	Dopamine D4 receptor	target
DB01403	Methotrimeprazine	Alpha-2A adrenergic receptor	target
DB01403	Methotrimeprazine	Alpha-2B adrenergic receptor	target
DB01403	Methotrimeprazine	Alpha-2C adrenergic receptor	target
DB01403	Methotrimeprazine	5-hydroxytryptamine receptor 2A	target
DB01403	Methotrimeprazine	5-hydroxytryptamine receptor 2C	target
DB01403	Methotrimeprazine	Cytochrome P450 2E1	enzyme

Drug	Drug Name	Phase	Status	Count